Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-26

Clinical Trial Update: Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of LP-003 injection in patients with moderate to severe seasonal allergic rhinitis; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LP-003

Snippet

Sponsor: Longbio Pharma | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING